Screener
60 Degrees Pharmaceuticals SXTP Q2 2025 earnings
Reported August 13, 2025 · Before market open
Revenue$100.9KMiss by $49.1K
EPS-$1.25Miss by $0.01
Revenue estimate$150.0K
EPS estimate-$1.24
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$270.0K
EPS estimate-$0.61
Versus estimates
Revenue
Diluted EPS
FAQ
- When did 60 Degrees Pharmaceuticals report Q2 2025 earnings?
- 60 Degrees Pharmaceuticals (SXTP) reported Q2 2025 earnings on August 13, 2025 before market open.
- What were 60 Degrees Pharmaceuticals's Q2 2025 revenue and EPS?
- 60 Degrees Pharmaceuticals reported revenue of $100.9K and eps of $-1.25 for Q2 2025.
- Did 60 Degrees Pharmaceuticals beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $150.0K by $49.1K. EPS missed the consensus estimate of $-1.24 by $0.01.
- How did 60 Degrees Pharmaceuticals's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 19.2% from $125.0K a year earlier and eps grew 94.1% from $-21.15.
- Where can I find 60 Degrees Pharmaceuticals's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001554855-25-001009) directly on SEC EDGAR. The filing index links above go to sec.gov.
